|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2004-5-18
|
|
pubmed:abstractText |
Chemokines are involved in the pathogenesis of multiple sclerosis. The aim of the study was to evaluate the effects of immunosuppressive therapy on production of two proinflammatory chemokines--interleukin-8 (IL-8) and RANTES (regulated on activation, normal T cell expressed and secreted).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0001-6314
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright Blackwell Munksgaard 2004
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
109
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
390-2
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15147461-Adult,
pubmed-meshheading:15147461-Chemokine CCL5,
pubmed-meshheading:15147461-Cladribine,
pubmed-meshheading:15147461-Female,
pubmed-meshheading:15147461-Humans,
pubmed-meshheading:15147461-Immunosuppressive Agents,
pubmed-meshheading:15147461-Injections, Subcutaneous,
pubmed-meshheading:15147461-Interleukin-8,
pubmed-meshheading:15147461-Male,
pubmed-meshheading:15147461-Multiple Sclerosis, Relapsing-Remitting
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Interleukin-8 and RANTES levels in patients with relapsing-remitting multiple sclerosis (RR-MS) treated with cladribine.
|
|
pubmed:affiliation |
Department of Neurology, Medical University, Lublin, Poland. halbp@poczta.onet.pl
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
